Verve Therapeutics (VERV) experienced a closing price of $5.64 on December 29, 2024, and December 31, 2024, which is slightly below the average forecasted price for the year1. This indicates that the stock's performance was somewhat lower than anticipated, suggesting potential challenges or setbacks for the company in the period.